Talis Biomedical Corporation TLIS
Set alert
2.84 USD +2.84 —
Day range unavailable
52-week range unavailable
- YTD
- 0.00%
- 1 year
- +71.08%
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 3.23M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.08
- Beta
- 1.56
- Short ratio
- 0.59
- Inst. own
- 55.06%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 24, 2024
- 50-d avg
- 1.89
- 200-d avg
- 6.59
- 1y target
- 0.00
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 2.13M | 4.81M | 8.19M | 10.94M | 3.98M | |
| 2.09M | -3.58M | 8.19M | 10.94M | 3.98M | |
| -66.81M | -115.14M | -191.82M | -91.18M | -26.70M | |
| -62.01M | -113.01M | -192.04M | -91.13M | -27.47M | |
| -34.12 | -62.77 | -127.20 | -644.70 | -191.55 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 76.73M | 130.19M | 232.54M | 173.13M | 21.60M | |
| 94.67M | 169.29M | 265.83M | 198.41M | 25.73M | |
| 25.56M | 42.55M | 31.85M | 16.03M | 4.12M | |
| 19.67M | 33.58M | 13.98M | 693.00K | 0 | |
| 69.12M | 126.74M | 233.98M | -108.57M | -21.14M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -53.24M | -100.14M | -171.38M | -87.02M | -24.33M | |
| -486.00K | -1.61M | -2.87M | -8.20M | -578.00K | |
| 33.00K | 406.00K | 234.43M | 246.75M | 39.61M | |
| -486.00K | -1.61M | -2.87M | -8.20M | -578.00K | |
| -53.69M | -101.34M | 60.18M | 151.53M | 14.71M |